Capacity building programme in The Gambia, October 2023

Nov 30, 2023 | Capacity building

Beginning of October 2023, Dr. Karim Bagaté, Director of Clinical Operations & Safety, and Mr. Assane Ndiaye, Clinical Research Associates Manager at Pharmalys delivered a capacity building programme, named ERC (Ethics and Regulatory Capacity) in The Gambia. The objective of this advanced workshop was to equip senior members of the National Ethics Committee for Life Sciences and Health authorities with the knowledge and skills they need to conduct high-quality ethics reviews, ensure optimal protection of research participants, and effectively manage and coordinate clinical trials. Karim and Assane provided a one-week intensive training course on Good Clinical Practice (GCP) and performed a clinical trial inspection. The training covered many topics from the drug development process and history of ICH GCP, to fraud, misconduct & research integrity, including the management of the investigational product, drug safety, and quality assurance to name but a few.
During the 2-day clinical trial site mock inspection, Pharmalys team ensured the staff were working in accordance with the protocol and GCP guidelines. They made a document inspection consisting of a document review to check the availability, completeness, authenticity, and GCP compliance of the documents, interviews with the investigational team to assess the site organisation and the team training, and a site visit to evaluate the organisation of the various sites.

Newsletter July 2024

Newsletter July 2024

Pharmalys Ltd: Our Commitment to Quality As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality...

Our Soft Skills Training Programme was a huge success!

Our Soft Skills Training Programme was a huge success!

Since 2008, Pharmalys Ltd has seen consistent growth, with a notable acceleration over the past two years, expanding from 30 to 50 employees. The Pharmalys team is primarily composed of remote workers spread across the globe, from USA to India, the UK to South Africa....

Barriers to cancer clinical trials participation

Barriers to cancer clinical trials participation

Ongoing cancer clinical trials in Africa in 2020 From Unger J.M. et al. JNCI J Natl Cancer Inst 2019. * Circles represent individual clinical trials * Colors of the circles represent the study’s primary sponsor type   The cancer clinical trials context Clinical...

Pharmalys Ltd: Our Commitment to Quality

Pharmalys Ltd: Our Commitment to Quality

As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality Management team is integral to all our services,...

Future prospects in clinical research

Future prospects in clinical research

Strategies for the future of clinical research: decentralised clinical trials Challenges with traditional clinical trials The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system...

Five reasons why we should invest in women-owned businesses

Five reasons why we should invest in women-owned businesses

In the pursuit of inclusive economic growth, one of the most important avenues to explore is the support of women-owned businesses. Across the globe, women entrepreneurs are not just contributors to economies, they are agents of change, driving innovation, creating...

Newsletter March 2024

Newsletter March 2024

  #CountAfricaIn in the field of clinical research Pharmalys team takes the floor! ­ Pharmalys team members give their feedback on how to improve the Pharmalys Voice concept Introduced in March 2023, Pharmalys Voice represents a recurrent team gathering designed...